Dr. Montserrat Arroyo is the Deputy Director General for Standards Setting and Implementation of the World Organisation for Animal Health (WOAH). She holds a degree in Veterinary Medicine and Animal Sciences from the National Autonomous University of Mexico (UNAM) and a master’s degree in Preventive Veterinary Medicine from the University of California, Davis.

In our “Coffee with the Expert” section, Dr. Montserrat Arroyo Kuribreña serves as Deputy Director General for Standards Setting and Implementation of the World...

A summary of the latest News & Alerts in the fields of vaccinology, vaccines, vaccination, and vaccine-preventable diseases. We curate the latest information on regulatory updates, emerging trends, breakthroughs in vaccine technology, vaccine safety and efficacy, global immunization developments and outbreak alerts, as a resource to keep our community informed.

Latest impactful scientific publications that stand out for their potential bearing on healthcare. We introduce groundbreaking research findings, innovative treatment modalities, results from phase 1 to 3 vaccine clinical trials, or paradigm-shifting discoveries that redefine our understanding of infectious diseases and therapeutic approaches for all vaccine-preventable diseases.

Introduction: Aluminum is a ubiquitous element in the environment and a common component of the human diet, with regular exposure occurring through multiple food sources....

Introduction: Chronic obstructive pulmonary disease (COPD) is highly susceptible to infectious triggers, with respiratory viruses and bacteria playing a central role in precipitating acute exacerbations....

The U.S. Food and Drug Administration’s (FDA’s) Center for Biologics Evaluation and Research (CBER) is responsible for regulating vaccine use in the United States. The general stages...

While most countries have established routine immunization programs, the COVID-19 pandemic highlighted critical vulnerabilities in the vaccine manufacturing and supply chain systems and significant gaps in equitable access to vaccines as essential medical countermeasures.(1,2)  During the COVID-19 pandemic, vaccines were developed at a record-breaking speed, only 10 months into the pandemic. However, access to COVID-19 vaccines was largely disparate with eight of every 10 vaccination doses having gone to high-income countries.(3) Of the just over six billion doses administered globally by the end of September 2021, 75% were administered in high- and upper-middle income countries (which constitute 50% of the global population) and only 25% in low- and low-middle income countries (which constitute the other 50%).(4)